Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000919574-21-006153
Filing Date
2021-10-07
Accepted
2021-10-07 15:31:40
Documents
1
Effectiveness Date
2021-10-07
Items
Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6220
  Complete submission text file 0000919574-21-006153.txt   7461
Mailing Address EUCLIDEAN TECHNOLOGIES MANAGEMENT, LLC 701 5TH AVENUE, SUITE 4200 SEATTLE WA 98104
Business Address EUCLIDEAN TECHNOLOGIES MANAGEMENT, LLC 701 5TH AVENUE, SUITE 4200 SEATTLE WA 98104 206-839-8586
Euclidean Fund For Cancer Research LP (Filer) CIK: 0001729236 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-311389 | Film No.: 211312323